Tag: biotechnology
-
Trial Testing Engineered Virus as Cancer Treatment
A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers.
-
Viruses Removed from Pig Organs for Human Transplants
Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants.
-
Gene-Edited Skin Grafts Shown to Control Glucose Levels
Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
Engineered Viruses Studied to Improve Plant Traits.
A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought.
-
RNA Vaccine for Rabies Found Safe, Generates Antibodies
A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies.
-
Faster Process Devised for Targeted Antibodies
Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies.
-
Lilly Licensing Autoimmune Therapy in $400M Deal
Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system.
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Biotech Licensing Viral T-Cell Immunotherapies
A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine.